Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome

American Journal of Cardiology

Volumn 98, Issue 8, 2006, Pages 1012-1017

  Liu, Ping Yen ^a,b   Li, Yi Heng ^a   Chan, Shih Hung ^a,b   Lin, Li Jen ^a   Wu, Hua Lin ^b   Shi, Guey Yueh ^b   Chen, Jyh Hong ^a  

^a Institute of Molecular and Cellular Biology   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; STROMELYSIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; STATISTICAL SIGNIFICANCE; TAIWAN;

ACUTE DISEASE; CASE-CONTROL STUDIES; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 33749240721     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.017     Document Type: Article

References (19)

1. Ye S., Watts G.F., Mandatia S., Humphries S.E., and Henney A.M. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73 (1995) 209-215
2. Liu P.Y., Chen J.H., Li Y.H., Wu H.L., and Shi G.Y. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost 90 (2003) 132-139
3. Beyzade S., Zhang S., Wong Y.K., Day I.N., Eriksson P., and Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41 (2003) 2130-2137
4. Rauramaa R., Vaisanen S.B., Luong L.A., Schmidt-Trucksass A., Penttila I.M., Bouchard C., Toyry J., and Humphries S.E. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 2657-2662
5. Hoppmann P., Koch W., Schomig A., and Kastrati A. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur Heart J 25 (2004) 335-341
6. Carty C.S., Soloway P.D., Kayastha S., Bauer J., Marsan B., Ricotta J.J., and Dryjski M. Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. J Vasc Surg 24 (1996) 927-934
7. Inoue T., Kato T., Takayanagi K., Uchida T., Yaguchi I., Kamishirado H., Morooka S., and Yoshimoto N. Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Am J Cardiol 92 (2003) 1461-1464
8. Sukhova G.K., Williams J.K., and Libby P. Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol 22 (2002) 1452-1458
9. de Maat M.P., Jukema J.W., Ye S., Zwinderman A.H., Moghaddam P.H., Beekman M., Kastelein J.J.P., van Boven A.J., Bruschke A.V.G., Humphries S.E., et al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis (REGRESS study). Am J Cardiol 83 (1999) 852-856
10. Liu P.Y., Tsai W.C., Lin C.C., Hsu C.H., Haung Y.Y., and Chen J.H. Invasive measurements of pulse wave velocity correlate with the degree of aortic valve calcification and severity associated with matrix metalloproteinases in elderly patients with aortic valve stenosis. Clin Sci (Lond) 107 (2004) 415-422
11. Liu P.Y., Li Y.H., Wu H.L., Chao T.H., Tsai L.M., Lin L.J., Shi G.Y., and Chen J.H. Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. J Thromb Haemost 4 (2006) 1023-1028
12. Watanabe N., and Ikeda U. Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6 (2004) 112-120
13. Ikeda U., Shimpo M., Ohki R., Inaba H., Takahashi M., Yamamoto K., and Shimada K. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension 36 (2000) 325-329
14. Richardson D.W., and Dodge G.R. Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res 52 (2003) 39-49
15. Dahlen B., Shute J., and Howarth P. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 54 (1999) 590-596
16. Terashima M., Akita H., Kanazawa K., Inoue N., Yamada S., Ito K., Matsuda Y., Takai E., Iwai C., Kurogane H., et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 99 (1999) 2717-2719
17. Ye S., Eriksson P., Hamsten A., Kirkinen M., Humphries S.E., and Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271 (1996) 13055-13060
18. Silence J., Lupu F., Collen D., and Lijnen H.R. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 21 (2001) 1440-1445
19. Humphries S.E., Marin S., Cooper J., and Miller G. Interaction between smoking and the stromelysi-1 (MMP-3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men. Ann Hum Genet 66 (2002) 343-352